First Affiliated Hospital of Wannan Medical College
40
16
17
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
2.5%
1 terminated/withdrawn out of 40 trials
83.3%
-3.2% vs industry average
23%
9 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
Role: lead
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
Role: lead
Effect of Nava on Weaning Outcome in Patients With Mechanical Ventilation
Role: collaborator
Assessing Local Hypothermia and Endovascular Recanalization for Acute Stroke With a Large Core Infarction
Role: lead
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
Role: lead
Epidemiology And Risk Factors Of Intradialytic Hypotension In Maintenance Hemodialysis Patients
Role: lead
The Feasibility of Pulmonary Perfusion Assessment Using Sodium Bicarbonate Contrast With Electrical Impedance Tomography: A Prospective Pilot Study
Role: lead
Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke
Role: lead
Time-restricted Enteral Nutrition Versus Continuous Enteral Nutrition in Patients With Severe Stroke
Role: lead
Hemoadsorption for Severe Ischemic Stroke
Role: lead
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Role: collaborator
Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock
Role: lead
Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension
Role: lead
Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension
Role: lead
Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD）
Role: lead
Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis
Role: lead
Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy
Role: lead
Endovascular Treatment of Cerebrovascular Diseases Guided by Optical Coherence Tomography (OCT) Technology（CVD-OCT）
Role: lead
Ultrasound-Guided Microbubble Removal and Filter Lifespan During CRRT: A Pilot Crossover Study
Role: lead
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response
Role: collaborator